Transcriptomic and experimental evidence confirm the potential of disulfidptosis-related signature for the early diagnosis and treatment of liver cirrhosis

• Yiqian Liu,

  Roles Conceptualization, Writing – original draft

  Affiliations Department of Gastroenterology and Hepatology, The First Hospital of Shanxi Medical University, Taiyuan, China, Experimental Center of Science and Research, The First Hospital of Shanxi Medical University, Taiyuan, China, Key Laboratory of Cellular Physiology of the Ministry of Education, Shanxi Medical University, Taiyuan, China, Translational Medicine Research Center, Shanxi Medical University, Taiyuan, China

  ⨯
• Ruixin Zhang,

  Roles Resources

  Affiliation Department of Gastroenterology and Hepatology, The First Hospital of Shanxi Medical University, Taiyuan, China

  ⨯
• Xiaojie Sun,

  Roles Visualization

  Affiliations Department of Health Management, The Sixth Clinical Medical College of Shanxi Medical University (Sixth Hospital of Shanxi Medical University), Taiyuan, China, Department of Health Management, General Hospital of Tisco, Taiyuan, China

  ⨯
• Wei Cui ,

  Roles Validation

  * E-mail: lixinliu6@sxmu.edu.cn (LL); weicui929@163.com (WC)

  Affiliation Department of Pathology, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China

  ⨯
• Lixin Liu

  Roles Conceptualization, Writing – review & editing

  * E-mail: lixinliu6@sxmu.edu.cn (LL); weicui929@163.com (WC)

  Affiliations Department of Gastroenterology and Hepatology, The First Hospital of Shanxi Medical University, Taiyuan, China, Experimental Center of Science and Research, The First Hospital of Shanxi Medical University, Taiyuan, China

  https://orcid.org/0000-0001-7585-9432

  ⨯